首页> 外文会议>International Conference on Medical Pharmacology >A Novel Human Cytotoxic Cell Activation Factor with anti-Cancer Activity
【24h】

A Novel Human Cytotoxic Cell Activation Factor with anti-Cancer Activity

机译:具有抗癌活性的新型人细胞毒性细胞活化因子

获取原文

摘要

We report the isolation of a novel human Cytotoxic Cell Activation Factor (CCAcF). We found that the cDNA of this protein is expressed mainly in the human pancreas and kidney and partially in the placenta. CCAcF is also expressed in monocytes and CD8 cells, but only when these cells are activated, not when they are in a resting state, while rested CD19 lymphocytes do express CCAcF. We showed that application of CCAcF to acute myeloid leukemia cells (U937 premeyloid cells), human melanoma (CAG), human pancreatic cancer cells (Panc1) and human prostate cancer cells (PC3) inhibits the proliferation in vitro. In contrast, CCAcF doesn't affect healthy cells. Treatment of mice with induced pancreatic cancer eradicated the tumor in 60% of the treated mice, even when treatment began in a late stage of cancer development.
机译:我们报告了一种新型人细胞毒性细胞活化因子(CCACF)的分离。我们发现该蛋白质的cDNA主要在人体胰腺和肾脏中表达,部分地在胎盘中表达。 CCACF也以单核细胞和CD8细胞表达,但只有当这些细胞被激活时,而不是当它们处于静态状态时,而恢复的CD19淋巴细胞表达CCACF。我们表明,CCACF对急性髓性白血病细胞(U937中常见细胞),人黑素瘤(CAG),人胰腺癌细胞(PANC1)和人前列腺癌细胞(PC3)的应用抑制了体外增殖。相比之下,CCACF不会影响健康的细胞。诱导胰腺癌的小鼠在治疗小鼠的60%中消除了肿瘤,即使治疗在癌症发育晚期的治疗中也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号